Clinical Trials

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moulton, L. H.
Right arrow Articles by Chaisson, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moulton, L. H.
Right arrow Articles by Chaisson, R. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Clinical Trials, Vol. 4, No. 2, 190-199 (2007)
DOI: 10.1177/1740774507076937

Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention

Lawrence H. Moulton

Departments of International Health and Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA, lmoulton{at}jhsph.edu

Jonathan E. Golub

Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Betina Durovni

Communicable Diseases Program, Municipal Health Secretariat, Rio de Janeiro, Brazil, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil

Solange C. Cavalcante

Communicable Diseases Program, Municipal Health Secretariat, Rio de Janeiro, Brazil, Research Institute Evandro Chagas, Oswaldo Cruz Foundation, Rio de Janeiro and Brazil

Antonio G. Pacheco

Communicable Diseases Program, Municipal Health Secretariat, Rio de Janeiro, Brazil, National School of Public Health, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil

Valeria Saraceni

Communicable Diseases Program, Municipal Health Secretariat, Rio de Janeiro, Brazil

Bonnie King

Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Richard E. Chaisson

Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Background Tuberculosis (TB) is a major public health problem in Rio de Janeiro, where a high proportion of HIV-infected adults are co-infected with latent TB. Health officials in Brazil have recommended that HIV patients be tested for TB infection and given TB prophylaxis (isoniazid) if positive. In practice, although Brazil is a model for provision of antiretroviral therapy to patients with advanced HIV disease, relatively few such patients receive TB testing and prevention services.

Purpose We initiated a randomized study of a health services intervention to train health personnel in implementation of the recommended routine of TB testing and isoniazid prophylaxis. The primary goal is to reduce incident TB disease in the HIV clinic population.

Methods The clinic-level intervention will be phased in gradually over the study period until all clinics have received the intervention. The clinics' order of initiation of intervention was randomized and subjected to constraints based on clinic-level covariates. This phased intervention cluster-randomized trial required special attention to power/sample size calculation and randomization procedures, of which we provide the relevant details.

Results Special design considerations accounted for within-clinic correlation, variation in the clinic size, time-varying ratio of intervention to control clinics and guaranteed post-randomization covariate balance. These were successfully implemented for the estimation of power and execution of the randomization strategy.

Limitations Although the design features of randomization by clinic and phased implementation of the intervention meet logistic and local needs, they substantially lower the statistical power of the study.

Conclusions Studies with cluster-randomized order of intervention introduction can provide useful information on intervention effects. Their design and analysis are more complicated than for individually randomized parallel design trials. The methods we describe represent practical approaches to the challenges raised in the course of designing this study. Clinical Trials 2007; 4: 190—199. http://ctj.sagepub.com


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Clin TrialsHome page
A. Chingono, T. Lane, A. Chitumba, M. Kulich, and S. Morin
Balancing science and community concerns in resource-limited settings: Project Accept in rural Zimbabwe
Clinical Trials, June 1, 2008; 5(3): 273 - 276.
[Abstract] [PDF]